UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data

European heart journal, 2020-08, Vol.41 (30), p.2863-2873

2020

Volltextzugriff (PDF)

Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation

British journal of pharmacology, 2024-02, Vol.181 (3), p.319-339

2024

Volltextzugriff (PDF)

Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

Hypertension (Dallas, Tex. 1979), 2023-04, Vol.80 (4), p.811-819

2023

Volltextzugriff (PDF)

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation

Frontiers in neuroscience, 2019-01, Vol.12, p.1058-1058

2019

Volltextzugriff (PDF)

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation

International journal of molecular sciences, 2021-04, Vol.22 (8), p.4241

2021

Volltextzugriff (PDF)

Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement

Journal of hypertension, 2024-12, Vol.42 (12), p.2025-2040

2024

Volltextzugriff (PDF)

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection

JACC. Basic to translational science, 2020-02, Vol.5 (2), p.169-179

2020

Volltextzugriff (PDF)

Towards Establishing Renal Denervation as the Third Pillar in Hypertension Treatment: The RADIANCE-HTN TRIO Trial

Cardiovascular and interventional radiology, 2021-12, Vol.44 (12), p.2015-2017

2021

Volltextzugriff (PDF)

Shades of grey: a matter relevant to sympathetic activity and blood pressure control?

Journal of hypertension, 2020-02, Vol.38 (2), p.206-207

2020

Volltextzugriff (PDF)

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i-Arrhythmias and Sudden Cardiac Death)

Cardiovascular diabetology, 2024-02, Vol.23 (1), p.78-78, Article 78

2024

Volltextzugriff (PDF)

Diuretics and skin cancer: should a common prescription come with advice to avoid sun exposure?

Journal of hypertension, 2019-10, Vol.37 (10), p.1961-1962

2019

Volltextzugriff (PDF)

Renal Denervation Update From the International Sympathetic Nervous System Summit

Journal of the American College of Cardiology, 2019-06, Vol.73 (23), p.3006-3017

2019

Volltextzugriff (PDF)

Effects of sympathetic modulation in metabolic disease

Annals of the New York Academy of Sciences, 2019-10, Vol.1454 (1), p.80-89

2019

Volltextzugriff (PDF)

Therapeutic inertia in hypertension management – status quo in primary care

Journal of hypertension, 2021-06, Vol.39 (6), p.1107-1108

2021

Volltextzugriff (PDF)

Capillary vascular density in the retina of hypertensive patients is associated with a non-dipping pattern independent of mean ambulatory blood pressure

Journal of hypertension, 2021-09, Vol.39 (9), p.1826-1834

2021

Volltextzugriff (PDF)

Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation

Journal of hypertension, 2024-05, Vol.42 (5), p.922-927

2024

Volltextzugriff (PDF)

Renal Denervation—Ready for Prime Time!?: The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment

Hypertension (Dallas, Tex. 1979), 2018-08, Vol.72 (2), p.287-290

2018

Volltextzugriff (PDF)

Vascular compression of the rostral ventrolateral medulla: a relevant indicator of sympathetically driven blood pressure variability?

Journal of hypertension, 2020-12, Vol.38 (12), p.2380-2381

2020

Volltextzugriff (PDF)

Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice

World journal of gastroenterology : WJG, 2020-06, Vol.26 (23), p.3225-3235

2020

Volltextzugriff (PDF)

Detection of autonomic dysfunction in hemodialysis patients using the exercise treadmill test: the role of the chronotropic index, heart rate recovery, and R-R variability

PloS one, 2015-06, Vol.10 (6), p.e0128123-e0128123

2015

Volltextzugriff (PDF)

Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches

Journal of hypertension, 2021-08, Vol.39 (8), p.1478-1489

2021

Volltextzugriff (PDF)

Update on advanced interventional neuromodulatory approaches to lower blood pressure

Heart (British Cardiac Society), 2023-12, Vol.109 (23), p.1734-1740

2023

Volltextzugriff (PDF)

The Schlager mouse as a model of altered retinal phenotype

Neural regeneration research, 2020-03, Vol.15 (3), p.512-518

2020

Volltextzugriff (PDF)

An evaluation of empagliflozin and it's applicability to hypertension as a therapeutic option

Expert opinion on pharmacotherapy, 2020-07, Vol.21 (10), p.1157-1166

2020

Volltextzugriff (PDF)

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy

The journal of clinical hypertension (Greenwich, Conn.), 2021-07, Vol.23 (7), p.1380-1389

2021

Volltextzugriff (PDF)

1 – 25 von 195

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(142)
Mit Volltextzugriff
(141)

Publikationsform

Artikel
(189)
Buchkapitel
(6)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Rhythm control for patients with atrial fibrillation complicated with heart failure in the contemporary era of catheter ablation: a stratified pooled analysis of randomized data

Taming resistant hypertension: The promise of novel pharmacologic approaches and renal denervation

Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension

Sympathetic Nervous System Activation and Its Modulation: Role in Atrial Fibrillation

Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)-A Condition Associated with Heightened Sympathetic Activation

Targeting the sympathetic nervous system with the selective imidazoline receptor agonist moxonidine for the management of hypertension: an international position statement

SGLT2 Inhibitor-Induced Sympathoinhibition: A Novel Mechanism for Cardiorenal Protection

Towards Establishing Renal Denervation as the Third Pillar in Hypertension Treatment: The RADIANCE-HTN TRIO Trial

Shades of grey: a matter relevant to sympathetic activity and blood pressure control?

Effect of SGLT-2 inhibitors on arrhythmia events: insight from an updated secondary analysis of > 80,000 patients (the SGLT2i-Arrhythmias and Sudden Cardiac Death)

Diuretics and skin cancer: should a common prescription come with advice to avoid sun exposure?

Renal Denervation Update From the International Sympathetic Nervous System Summit

Effects of sympathetic modulation in metabolic disease

Therapeutic inertia in hypertension management – status quo in primary care

Capillary vascular density in the retina of hypertensive patients is associated with a non-dipping pattern independent of mean ambulatory blood pressure

Salt sensitivity risk derived from nocturnal dipping and 24-h heart rate predicts long-term blood pressure reduction following renal denervation

Renal Denervation—Ready for Prime Time!?: The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment

Vascular compression of the rostral ventrolateral medulla: a relevant indicator of sympathetically driven blood pressure variability?

Sodium glucose co-transporter 2 inhibition reduces succinate levels in diabetic mice

Detection of autonomic dysfunction in hemodialysis patients using the exercise treadmill test: the role of the chronotropic index, heart rate recovery, and R-R variability

Role of the sympathetic nervous system in cardiometabolic control: implications for targeted multiorgan neuromodulation approaches

Update on advanced interventional neuromodulatory approaches to lower blood pressure

The Schlager mouse as a model of altered retinal phenotype

An evaluation of empagliflozin and it's applicability to hypertension as a therapeutic option

Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first‐line antihypertensive therapy

Suchergebnisse filtern